Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors

被引:25
作者
Guimaraes, S [1 ]
Pinheiro, H [1 ]
Tavares, P [1 ]
Loio, A [1 ]
Moura, D [1 ]
机构
[1] Inst Pharmacol & Therapeut, Fac Med, P-4200319 Porto, Portugal
关键词
eprosartan; losartan; PB123319; angiotensin II receptors; rat ventricle; canine pulmonary artery;
D O I
10.1007/s002100100396
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A comparison was made of the influence of losartan and eprosartan on angiotensin II effects at pre- and postjunctional receptors of the canine pulmonary artery and at prejunctional receptors of the rat left ventricle. To study postjunctional contractile responses to angio-tensin II, non-cumulative concentration-response curves were determined, to study prejunctional effects of angiotensin II, the tissues were preincubated with [H-3]noradrenaline and then superfused and electrically stimulated (1 Hz, 2 ms, 50 mA, 5 min). Postjunctionally, both losartan and eprosartan caused a parallel shift of the concentration-response curve of angiotensin II to the right (pK(d) of 8.15 and 8.28, respectively). At the prejunctional level, while eprosartan, in concentrations similar to those which were effective postjunctionally (36-100 nM), antagonized the facilitatory effect on noradrenaline release in both the dog pulmonary artery and the rat ventricle, Iosartan was ineffective in concentrations up to 1 muM. It is concluded that prejunctional receptors for angiotensin II in the canine pulmonary artery and in the rat left ventricle are different from postjunctional receptors of the canine pulmonary artery. It is proposed that the prejunctional receptors of these tissues are atypical AT(1) or "AT(1B)-like" receptors.
引用
收藏
页码:509 / 514
页数:6
相关论文
共 50 条
  • [41] HEMODYNAMIC AND NEUROHORMONAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    GOTTLIEB, SS
    DICKSTEIN, K
    FLECK, E
    KOSTIS, J
    LEVINE, TB
    LEJEMTEL, T
    DEKOCK, M
    [J]. CIRCULATION, 1993, 88 (04) : 1602 - 1609
  • [42] In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: A comparison with losartan
    Fabiani, ME
    Dinh, DT
    Nassis, L
    Casley, DJ
    Johnston, CI
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (09) : 1005 - 1013
  • [43] DISCOVERY OF LOSARTAN, THE 1ST SPECIFIC NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    SIEGL, PKS
    [J]. JOURNAL OF HYPERTENSION, 1993, 11 : S19 - S22
  • [44] Stress and brain angiotensin II receptors
    Watanabe, T
    Fujioka, T
    Hashimoto, M
    Nakamura, S
    [J]. CRITICAL REVIEWS IN NEUROBIOLOGY, 1998, 12 (04): : 305 - 317
  • [45] A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension
    Hedner, T
    Oparil, S
    Rasmussen, K
    Rapelli, A
    Gatlin, M
    Kobi, P
    Sullivan, J
    Oddou-Stock, P
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 414 - 417
  • [46] Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?
    Michele A. Tedesco
    Gennaro Ratti
    Giovanni Di Salvo
    Francesco Natale
    [J]. Drugs & Aging, 2002, 19 : 723 - 732
  • [47] Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans
    Gandhi, SK
    Ryder, DH
    Brown, NJ
    [J]. HYPERTENSION, 1996, 28 (06) : 961 - 966
  • [48] COMPETITIVE ANTAGONISM OF PRESSOR-RESPONSES TO ANGIOTENSIN-II AND ANGIOTENSIN-III BY THE ANGIOTENSIN-II-1 RECEPTOR LIGAND LOSARTAN
    ABDELRAHMAN, A
    PANG, CCY
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (05) : 716 - 719
  • [49] Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteers
    Tenero, DM
    Martin, DE
    Ilson, BE
    Boyle, DA
    Boike, SC
    Carr, AM
    Lundberg, DE
    Jorkasky, DK
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) : 304 - 308
  • [50] Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries
    Guimaräes, S
    Paiva, MQ
    Moura, D
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) : 1207 - 1212